Dr Ashleigh Poh
The Olivia Newton-John Cancer Research Institute
Colon, Melanoma, Lung
(Jul 2017-Jun 2018)
What is the project?
This project exploits expression of the protein Haematopoietic Cell Kinase (HCK) as a novel target to improve the anti-cancer effects of immunotherapy and chemotherapy. The findings from this study will provide important mechanistic insights and pre-cinical proof-of-concept data to support future clinical trials with anti-HCK drugs to reduce tumour growth in patients.
Cancer Council Postdoctoral Fellowship